Abstract

Summary

This paper discusses the development of a novel protocol for retinal ganglion cell (RGC) differentiation from human pluripotent stem cells, and the potential applications of this protocol in the treatment of vision loss and blindness from glaucoma and other forms of optic nerve disease.
Categories

Categories

Eye health: The paper discusses the development of a protocol for retinal ganglion cell differentiation, which could be used in the treatment of diseases such as glaucoma that cause vision loss and blindness.
Education and learning: The paper provides a detailed explanation of the protocol developed for retinal ganglion cell differentiation, contributing to the body of knowledge in this field.
Patient recovery and healing: The paper discusses the potential applications of the protocol in the treatment of vision loss and blindness, contributing to patient recovery and healing.
Authors

Author(s)

VM Sluch
Publication Date

Publication Year

2015
View more publications